Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: Analysis by northern blotting and in situ hybridization

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 286-292

  Morita, Sumihito ^a   Sato, Atsuhiko ^a   Hayakawa, Hiroshi ^a   Ihara, Hayato ^a   Urano, Tetsumei ^a   Takada, Yumiko ^a   Takada, Akikazu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG NON SMALL CELL CANCER; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; IN SITU HYBRIDIZATION; LUNG; LUNG NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 2; RECEPTORS, CELL SURFACE; REFERENCE VALUES; RNA, MESSENGER; TRANSCRIPTION, GENETIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032578687     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<286::AID-IJC4>3.0.CO;2-R     Document Type: Article

References (21)

1. BAKER, M.S., BLEAKLEY, P., WOODROW, G.G. and DOE, W.F., Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Res., 50, 4676-4684 (1990).
2. BLASI, F. and 18 OTHERS, The urokinase receptor: structure, regulation and inhibitor-mediated internalization. Fibrinolysis, 8 (Suppl. 1), 182-188 (1994).
3. COLBY, T.V., Koss, M.N. and TRAVIS, W.D., Atlas of tumor pathology. Tumors of the lower respiratory tract, pp. 107-134, Armed Forces Institute of Pathology, Washington, D.C. (1995).
4. DANø, K., BEHRENDT, N., BRÜNNER, N., ELLIS, V., PLOUG, M. and PYKE, C., The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8 (Suppl. 1), 189-203 (1994).
5. EVANS, D.M. and LIN, P.L., Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor. Amer. Surg., 61, 692-696 (1995).
6. FOEKENS, J.A., BUESSECKER, F., PETERS, H.A., KRAINICK, U., VAN PUTTEN, W.L.J., LOOK, M.P., KLIJN, J.G.M. and KRAMER, M.D., Plasminogen activator inhibitor-2: prognostic relevance in 1,012 patients with primary breast cancer. Cancer Res., 55, 1423-1427 (1995).
7. GLADSON, C.L., PIJUAN-THOMPSON, V., OLMAN, M.A., GILLESPIE, G.Y. and YACOUB, I.Z., Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Amer. J. Pathol., 146, 1150-1160 (1995).
8. MUELLER, B.M., Yu, Y.B. and LAUG, W.L., Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc. nat. Acad. Sci. (Wash.), 92, 205-209 (1995).
9. NAGAYAMA, M., SATO, A., HAYAKAWA, H., URANO, T., TAKADA, Y. and TAKADA, A., Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer, 73, 1398-1405 (1994).
10. ORNSTEIN, D.L., ZACHARSKI, L.R., MEMOLI, V.A., KISIEL, W., KUDRYK, B.J., HUNT, J., ROUSSEAU, S.M. and STUMP, D.C., Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissue. Cancer, 68, 1061-1067 (1991).
11. POSTE, G. and FIDLER, I.J., The pathogenesis of cancer metastasis Nature (Lond.), 283, 139-146 (1980).
12. ROLDAN, A.L., CUBELLIS, M.V., MASUCCI, M.T., BEHRENDT, N., LUND, L.R., DANØ, K., APPELLA, E. and BLASI, F., Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J., 9, 467-474 (1990).
13. SAPPING, A.-D., BELIN, D., HUARTE, J., HIRSCHEL-SCHOLZ, S., SAURAT, J.-H. and VASSALLI, J.-D., Differential protease expression by cutaneous squamous and basal cell carcinomas. J. clin. Invest, 88, 1073-1079 (1991).
14. SHETTY, S., KUMAR, A., JOHNSON, A.R., PUEBLITZ, S., HOLIDAY, D., RAGHU, G. and IDELL, S., Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Amer, J. respir. Cell Mol. Biol., 15, 78-87 (1996).
15. SOFF, G.A., SANDEROWTTZ, J., GATELY, S., VERRUSIO, E., WEISS, I., BREM, S. and KWAAN, H.C., Expression of plasminogen activator type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis and metastasis to lung and liver in an athymic mouse model. J. clin. Invest., 96, 2593-2600 (1995).
16. SUMIYOSHI, K., URANO, T., TAKADA, Y. and TAKADA, A., PAI-1 and PAI-2 levels as predictors in staging malignancy in breast cancer. In: P. Glas-Greenwalt (ed.)., Fibrinolysis in disease: the malignant process, interven tions in rhrombogenic mechanisms and novel treatment modalities, pp. 26-30, CRC Press, Boca Raton, FL (1995).
17. VASSALLI, J.-D., The urokinase: receptor. Fibrinolysis, 8.(Suppl. 1), 172-181 (1994).
18. WAGNER, S.N., ATKINSON, M.J., THANNER, S., WAGNER, C., SCHMITT, M., WILHELM, O., ROTTER, M. and HÖFLER, H. Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Amer. J. Pathol., 147, 183-192 (1995).
19. YHAMOTO, M., SAWAYA, R., MOHANAM, S., LOSKUTOFF, D.J., BRUNER, J.M., RAO, V.H., OKA, K., TOMONAGA, M., NICOLSON, G.L. and RAO, J.S., Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo. Cancer Res., 54, 3329-3332 (1994a).
20. YAMAMOTO, M., SAWAYA, R., MOHANAM, S., RAO, V.H., BRUNER, J.M., NICOLSON, G.L. and RAO, J.S., Expression and localization of urokihase-type plasminogen activator receptor in human gliomas. Cancer Res., 54, 5016-5020 (1994B).
21. ZHENG, M.H., FAN, Y., PANICKER, A., SMITH, A., ROBERTSON, T., WYSOCKI, S., ROBBINS, P., PAPADIMITRIOU, J.M. and WOOD, D.J., Detection of mRNAs for urokinase-type plasminogen activator, its receptor and type-1 inhibitor in giant cell tumors of bone with in situ hybridization. Amer. J. Pathol., 147, 1559-1566 (1995).